Status:
NOT_YET_RECRUITING
The Agenda-Setting for Kidney Disease Open Pilot Trial
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Chronic Kidney Disease Stage 4
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this open pilot is to practice using an intervention and surveys before a larger pilot stepped wedge clinical trial. The intervention the researchers plan to use is Chronic Kidney Disease ...
Detailed Description
In this open pilot, the researchers will administer a novel structured agenda-setting tool (SAS) called Chronic Kidney Disease (CKD) Topics. The researchers will determine if their procedures for scre...
Eligibility Criteria
Inclusion
- Adults \>18 years old who have been diagnosed with advanced CKD (stages 4-5).
- Care partners, clinicians and staff supporting these CKD patients who are willing and able to provide informed consent
- English-speaking
- Able to provide informed consent
- Patient must be attending outpatient visits \*(in-person and/or telehealth allowable).
Exclusion
- Children under 18 years old will not be included
- Non-English-speaking patients and/or care partners
- Patients on dialysis
- Individuals unable or unwilling to provide informed consent
Key Trial Info
Start Date :
July 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07221604
Start Date
July 1 2026
End Date
September 1 2026
Last Update
October 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03766